CLEC1B and metastatic neoplasm: In this concept, platelet CLEC-2 is shed, and sCLEC-2 is trapped in the microenvironment of primary or metastatic tumors, leading to reduced sCLEC-2 levels in the blood plasma of patients with cancer.